ライフサイエンスコーパス: ICG

1 ICG also visualized electrical activity induced in livin

2 ICG angiograms revealed choriocapillaris loss in large l

3 ICG angiographic CNV surface areas were measured at base

4 ICG can be entrapped in the crosslinked HD/Se hydrogel n

5 ICG Ingress (p = 0.0027), donor age (p = 0.0452), recipi

6 ICG Ingress correlated significantly with recipient age

7 ICG was conjugated to the antibodies daclizumab (Dac), t

8 ICG was found to localize with TBRs greater than 2.0 (me

9 ICG-(99m)Tc-nanocolloid helped guide surgical excision o

10 ICG-(99m)Tc-nanocolloid was injected intraprostatically,

11 ICG-001 also inhibited C666-1 tumor sphere formation, ac

12 ICG-001 inhibited alpha-SMA expression/transcription in

13 ICG-001 is a novel small-molecule modulator of Wnt/caten

14 ICG-001 is a small-molecule inhibitor that specifically

15 ICG-001 is a specific CBP/beta-catenin antagonist that c

16 ICG-001 selectively blocks the beta-catenin/CBP interact

17 ICG-001 suppressed beta-catenin-driven gene transcriptio

18 ICG-001 was also found to restore the expression of a tu

19 ICG-assisted NIR fluorescence imaging can serve as a use

20 ICG-encapsulated poly(N-isopropylacrylamide) nanoparticl

21 ICG-PDR significantly deteriorated after TIPS (P = .006)

22 ICG-r15 and Lok index were independently related to the

23 ICG-r15 values (<6.7% and <6.9%, respectively) were able

24 = .001]), rate of CG symptom reduction (1.05 ICG points per week for CGT vs 0.75 points per week for

25 sence of CSPH and SPH (LR(-) 0.15 and 0.14); ICG-r15 <10% provided a 97.8% sensitivity (LR(-) 0.042)

26 whereas only the singly modified ASL(Arg1,2)(ICG) with I(34) was able to decode CGA.

27 ion of s(2)C(32) or m(2)A(37) to ASL(Arg1,2)(ICG), the maximum amount of ASL bound to CGU and CGC was

28 igh dual-drug loading ( approximately 92wt%) ICG-EPI NPs showed good physiological stability, prefera

29 Administering ICG using sublingual films displayed notable potential f

30 SLNs and lymphatic vessels before and after ICG injection.

31 ced by concentration quenching in aggregated ICG imbedded in the mesopourous silica shell to enable b

32 Although ICG has vast potential for non-invasive non-radioactive

33 n face (coronal, C-scan) OCT image and of an ICG angiogram, displayed side by side and superimposed,

34 -three consecutive patients who underwent an ICG clearance test and gadoxetate disodium-enhanced MR i

35 , 41.5 years +/- 20.2) were examined with an ICG-enhanced fluorescence molecular tomography (FMT) sys

36 higher contrast than its fluorescent analog ICG-pHLIP, which was developed for fluorescence-guided s

37 Ultra-widefield AF and ICG angiography in CSC revealed more widespread disease

38 erence tomography (OCT) characterization and ICG-assisted ILM peeling during surgery with intraocular

39 tivariate analysis identified 6 clinical and ICG variables that independently predicted an event with

40 Findings on SD-OCT, FA, digital FAF, and ICG-A images.

41 The FFA and ICG in 7 and 11 patients, respectively, showed some vasc

42 The FFA and ICG were screened for any vascular abnormalities.

43 ized with coronal (C-scans, en face) OCT and ICG angiography simultaneously.

44 The OCT, confocal SLO and ICG fluorescence images were simultaneously presented in

45 echanism of cytotoxicity of ICG solution and ICG conjugated micelles, respectively.

46 baseline and selected follow-up visits) and ICG-A under certain conditions.

47 hy (FFA), and indocyanine green angiography (ICG) by 2 independent observers.

48 Indocyanine green angiography (ICG) was used to identify the active areas and these "ho

49 Indocyanine-green angiography (ICG-A) may be considered at baseline under certain condi

50 omplexes are superior to clinically approved ICG for lymph node imaging deep within the mouse body.

51 he plasma staining that results from aqueous ICG's high affinity for plasma proteins, high contrast w

52 l structures of variously modified ASL(Arg1)(ICG) and ASL(Arg2)(ICG) constructs bound to cognate and

53 iously modified ASL(Arg1)(ICG) and ASL(Arg2)(ICG) constructs bound to cognate and wobble codons on th

54 nical value of ICG, non-toxic chitosan-based ICG-loaded films were designed for sublingual administra

55 Because ICG has voltage-sensitive properties in the entire heart

56 ied out to establish the correlation between ICG pHLIP imaging and white light pathological assessmen

57 rences in the SN identification rate between ICG-(99m)Tc-nanocolloid and (99m)Tc-nanocolloid.

58 urvivin promoter by CBP that is decreased by ICG-001 in primary ALL.

59 a-catenin signaling pathway was inhibited by ICG-001, a beta-Catenin inhibitor, which reversed the pr

60 r surgery, the ILM flap may be visualized by ICG fluorescence imaging.

61 with hepatobiliary- and glomerular-clearable ICG.

62 Among these are two compounds, ICG-001, targeting CREB binding protein (CREBBP), and PK

63 In this study, we have covalently conjugated ICG-NH2 to the pendant carboxyl groups of poly (ethylene

64 tumors were specifically visualized with Dac-ICG.

65 a recent episode of clinical decompensation, ICG can identify patients at increased near-term risk of

66 m formulations were developed with different ICG release rates.

67 ng CdTeS QDs was linked to near infrared dye ICG-Der-02 (MPA) by the peptide for measurement in vivo.

68 studied relative to a benchmark cyanine dye (ICG) during photoexcitation with exceptional photostabil

69 traprostatic tracer administration of either ICG-(99m)Tc-nanocolloid (hybrid tracer group) or (99m)Tc

70 the fact that the secretion pathway enables ICG-PEG45 to be effectively effluxed out of normal proxi

71 ermal toxicity was observed for encapsulated ICG as compared to free ICG at 808 nm laser irradiation

72 Based on the FFA, ICG, and SS-OCT imaging, there were 3 patients with no D

73 different voltage-sensitivity mechanisms for ICG.

74 ted occur C-terminal to the binding site for ICG-001.

75 The cutoff value for ICG Ingress was 106.23 AU with sensitivity of 78.3% and

76 Free ICG, at 0.25 mg/kg of patient weight, was intravenous (I

77 )Tc-nanocolloid was shown to outperform free ICG.

78 ved for encapsulated ICG as compared to free ICG at 808 nm laser irradiation with radiant exposure of

79 oted cellular endocytosis compared with free ICG or EPI.

80 c-nanocolloid was shown to outperform "free" ICG.

81 ee" ICG immediately prior to surgery ("free" ICG group).

82 cer group and 51.8% of the SNs in the "free" ICG group were removed solely under fluorescence-guidanc

83 the hybrid tracer group and 15 in the "free" ICG group).

84 (6 in the hybrid group and 12 in the "free" ICG group).

85 In the "free" ICG group, ex vivo evaluation of the excised specimens r

86 r group and in 20% of patients in the "free" ICG group.

87 99m)Tc-nanocolloid were injected with "free" ICG immediately before surgery.

88 99m)Tc-nanocolloid were injected with "free" ICG immediately prior to surgery ("free" ICG group).

89 racer group and 51.8% of the SNs in the free-ICG group were removed solely under fluorescence guidanc

90 n the hybrid-tracer group and 15 in the free-ICG group).

91 ed (6 in the hybrid group and 12 in the free-ICG group).

92 In the free-ICG group, ex vivo evaluation of the excised specimens r

93 tracer group and 20% of patients in the free-ICG group.

94 Furthermore, ICG-FI findings resulted in modification of the planned

95 Furthermore, ICG-FI findings resulted in modification of the planned

96 ociations between perfusion parameters (e.g. ICG Ingress) and donor, recipient, periprocedural, and p

97 tumors from animals injected with DM-Dual Gd-ICG had increased fluorescence (p < 0.05, n = 6).

98 on MR two days after intravenous DM-Dual Gd-ICG injection compared to controls (SNR, CNR, p < 0.05,

99 her a dual-mode, dual-Gadolinium (DM-Dual-Gd-ICG) contrast agent can be used to visualize ovarian tum

100 However, the first-generation ICG-NPs have a short shelf life (<1 month).

101 creases the shelf life of the new-generation ICG-NPs (>6 months).

102 ts received second window indocyanine green (ICG) (2.5-5 mg/kg) 24 hours prior to pancreatic resectio

103 sence dental imaging with indocyanine green (ICG) agent that has rarely been applied in dental imagin

104 ng of the fluorescent dye indocyanine green (ICG) and (99m)Tc-nanocolloid with the drainage pattern o

105 Indocyanine green (ICG) and epirubicin (EPI) could co-self-assemble into sm

106 ations capable of loading indocyanine green (ICG) and therapeutic genes were prepared to achieve a fl

107 ance (IR) photographs and indocyanine green (ICG) angiograms.

108 d fluorescein angiography/indocyanine green (ICG) angiography findings, of patients with a disseminat

109 Indocyanine green (ICG) aqueous angiography established initial baseline na

110 ge, clinical potential of indocyanine green (ICG) as PT is limited by its short half-life and ineffic

111 assessed by clearance of indocyanine green (ICG) at 4, 20 and 28 hours.

112 on were determined by the indocyanine green (ICG) clearance test.

113 We report indocyanine green (ICG) conjugated with a 2100 Da PEG molecule (ICG-PEG45)

114 The near-infrared dye indocyanine green (ICG) could serve as a basis for such a material, but its

115 e was used to encapsulate indocyanine green (ICG) dye in erythrocyte ghost cells at a concentration t

116 s a novel technique where indocyanine green (ICG) dye is sequestered in erythrocyte ghosts and autolo

117 iron oxide particles and indocyanine green (ICG) encapsulated in the NPs as tracers.

118 e ability of quantitative indocyanine green (ICG) fluorescence angiography for the short-term postope

119 OCT and indocyanine green (ICG) fluorescence were used to evaluate the MH and the I

120 erative injection of free indocyanine green (ICG) in the detection of peritoneal metastases (PM) due

121 by as much as 36.3%, and indocyanine green (ICG) increased signal magnitudes by as much as 38.1%.

122 ilogram of body weight of indocyanine green (ICG) intravenously 24 hours prior to their scheduled pro

123 uorescence; however, only indocyanine green (ICG) is clinically approved.

124 f CM, the photosensitizer indocyanine green (ICG) is successfully loaded and retained in the cavity o

125 Indocyanine green (ICG) is the most commonly used FDA-approved agent for cl

126 as measured at day 60 via indocyanine green (ICG) lymphography, after which animals were sacrificed f

127 cated that (1) formulated indocyanine green (ICG) readily penetrated hyperkeratotic PC skin and norma

128 te the performance of the indocyanine green (ICG) retention test as a noninvasive marker of PH and EV

129 Both indocyanine green (ICG) solution and TA suspension, at 50muL, 100muL, and 1

130 Indocyanine green (ICG) stain was used in 22 eyes (25.2%).

131 Indocyanine green (ICG) was administered intravenously 15 minutes later.

132 complished with NIR using indocyanine green (ICG), a nonspecific dye that has comparatively poor fluo

133 Here we report that indocyanine green (ICG), an infrared fluorescent dye with FDA approval as a

134 ressurized cuff occluding indocyanine green (ICG), demonstrated an increase in vessels afferent to ex

135 -dopamine (HD), including indocyanine green (ICG), were developed for local therapy of breast cancer.

136 dely used fluorescent dye indocyanine green (ICG), which has FDA approval, exhibits voltage sensitivi

137 administration of either indocyanine green (ICG)-(99m)Tc-nanocolloid (hybrid-tracer group) or (99m)T

138 tion of the hybrid tracer indocyanine green (ICG)-(99m)Tc-nanocolloid enables both preoperative senti

139 sentinel node (SN) tracer indocyanine green (ICG)-(99m)Tc-nanocolloid generates temporary tattoolike

140 fluorophore outperformed indocyanine green (ICG)-a clinically approved NIR-I dye-in resolving mouse

141 yte-ghosts and doped with Indocyanine Green (ICG).

142 ter systemic injection of indocyanine green (ICG).

143 scence (NIR) images using Indocyanine green (ICG).

144 infrared fluorescent dye [indocyanine green (ICG)] targets low extracellular pH, allowing visualizati

145 st 30 on the Inventory of Complicated Grief (ICG).

146 es with a particle size of 30-50 nm and high ICG loading.

147 TMB in initially high ICG signal regions led to faster development of fluoresc

148 In humans, ICG labels excitable cells and is routinely visualized t

149 uidance, warrants wider evaluation of hybrid ICG-(99m)Tc-nanocolloid as a tracer for sentinel node pr

150 edure was repeated after injection of hybrid ICG-(99m)Tc-nanocolloid the same afternoon in 10 patient

151 ion of the plasma disappearance rate of ICG (ICG-PDR) and various factors derived from MR imaging, in

152 hotoacoustic imaging was applied to identify ICG-dyed SLNs.

153 luorescence imaging system was used to image ICG fluorescence in biopsy samples.

154 Importantly, ICG-001 does not inhibit the p300/catenin interaction.

155 Importantly, ICG-001, regardless of CBP mutational status and chromos

156 P-673451) and a Wnt/ beta-catenin inhibitor (ICG-001) had potent inhibitory effects on liposarcoma ce

157 treatment with the small molecule inhibitor, ICG-001, inhibits leptin-induced EMT, invasion, and tumo

158 After cell binding and internalization, ICG dissociates from the targeting antibody, thus activa

159 , the surgery was modified by intraoperative ICG-FI, which detected additional PM not found using vis

160 complete tumor regression in NIR irradiated ICG conjugated micelles compared to ICG solution and con

161 = 3) before and after injection of 1 mmol/L ICG.

162 ach eye, for each stent TMB in initially low ICG angiographic signal regions showed transient or pers

163 High-speed, high-magnification ICG angiograms showing individual cell movement were rec

164 n the unilateral ureteral obstruction model, ICG-001 ameliorated renal interstitial fibrosis and supp

165 fficacy of the peptidomimetic small molecule ICG-001, which specifically disrupts beta-catenin-mediat

166 ICG) conjugated with a 2100 Da PEG molecule (ICG-PEG45) as a renal-tubule-secreted near-infrared-emit

167 We demonstrate that this UCNP@mSiO2-ICG nanoplatform can perform the following multiple func

168 Our results demonstrated that UCNP@mSiO2-ICG with sealed structures could be systemically deliver

169 d poly(N-isopropylacrylamide) nanoparticles (ICG-NPs) are one of the families of the most successful

170 Adjunct use of NIRF-ICG for (a) intraoperative sentinel lymph node mapping f

171 in 25 h), allowing for steady absorption of ICG to systemic circulation.

172 ectal metastases after the administration of ICG (n = 15) at 3, 6, and 24 hours after injection.

173 Late administration of ICG-001 also effectively attenuated fibrotic lesions in

174 Administration of ICG-001 concurrent with bleomycin prevents fibrosis, and

175 zinc(II)-dipicolylamine-assisted assembly of ICG, as well as simultaneous targeted gene delivery in a

176 Combination of ICG-001 with cisplatin synergistically suppressed in vit

177 ell containing sealed, high concentration of ICG molecules.

178 photothermal as mechanism of cytotoxicity of ICG solution and ICG conjugated micelles, respectively.

179 e traditional superficial 3 or 4 deposits of ICG-(99m)Tc-nanocolloid (0.1 mL each), and in 12 patient

180 This finding suggests better distribution of ICG solution than TA suspension in the suprachoroidal sp

181 This antifibrotic effect of ICG-001 did not involve disruption of Smad signaling.

182 is study, we aimed to evaluate the effect of ICG-001 on the CSC-like population, and the combination

183 ke population, and the combination effect of ICG-001 with cisplatin in the C666-1 EBV-positive NPC ce

184 and investigated the photothermal effects of ICG containing nanocapsules on EGFR-rich tumor cells.

185 The fluorescence of ICG can follow action potentials in artificial neurons a

186 in nude mice, and epifluorescence imaging of ICG, as well as histologic analysis of the explanted liv

187 There was avid localization of ICG to the focal lesions at all time points.

188 nto the liver, and real-time measurements of ICG fluorescence were obtained.

189 The fluorescent nature of ICG-(99m)Tc-nanocolloid supported in vivo and ex vivo id

190 The lymphatic drainage pattern of ICG-(99m)Tc-nanocolloid is identical to that of (99m)Tc-

191 to quantify tissue attenuation properties of ICG in liver parenchyma.

192 relation of the plasma disappearance rate of ICG (ICG-PDR) and various factors derived from MR imagin

193 s the leak-out and improves the stability of ICG by protecting from rapid hydrolysis.

194 PTT, the combinational chemo-PTT therapy of ICG-EPI NPs with NIR laser irradiation synergistically i

195 To expand the clinical value of ICG, non-toxic chitosan-based ICG-loaded films were desi

196 Equivalent volume of ICG solution led to a significantly smaller IOP elevatio

197 l analysis, we found the peak wavelengths of ICG fluorescence shifted along with the injection time:

198 fluorescein angiography, hypofluorescent on ICG angiography, and correlated with choroidal lesions o

199 ur study suggests that change in CNV size on ICG angiography may help the clinician predict the clini

200 In patients receiving the optimized ICG injection, there was significantly increased likelih

201 n reflectance was enhanced after nigrosin or ICG was injected into the systemic circulation.

202 cessfully characterized in vivo by using Pan-ICG(1:5) and Tra-ICG(1:5), respectively.

203 The parameter ICG Ingress reflects recipient and procedure characteris

204 apping and lymphadenectomy after peritumoral ICG injection.

205 pHLIP ICG is non-toxic, marks blood flow for hours after injec

206 Intravenously administered pHLIP ICG exhibits a multi-hour circulation half-life, offerin

207 As it clears from the blood, pHLIP ICG targets tumors and tumor stroma, marking them for su

208 d the biodistribution and clearance of pHLIP ICG in mice.

209 We studied pHLIP ICG interaction with the cell membrane lipid bilayer, th

210 fluorescent agent for use in surgery, pHLIP ICG, where ICG (indocyanine green) is a surgical fluores

211 The pHLIP ICG tumor targeting and imaging efficacy studies were ca

212 ly slower lymphatic drainage for 6 days post-ICG injection (P < 0.05).

213 After 6 hours of PP, ICG clearance increased (P < 0.001), indicating a compen

214 Compared to pure ICG, sealing of mesoporous silica platforms prevents the

215 indocyanine green plasma disappearance rate [ICG-PDR]) was performed.

216 Reinjected ICG-loaded erythrocytes permit routine visualization of

217 h contrast was maintained between reinjected ICG-loaded erythrocytes and their plasma background.

218 Regular films released ICG slowly (80% in 25 h), allowing for steady absorption

219 sted self-emulsifying films rapidly released ICG (80% in 4 h) in the form of nanosized droplets, whic

220 easurement, and the ICG 15-minute retention (ICG-r15) test.

221 noted, the mild photothermal effect of Au@Rh-ICG-CM also improves PDT efficacy.

222 ermal effect into a single nanosystem, Au@Rh-ICG-CM can readily serve as a promising nanoplatform for

223 o and in vivo results demonstrate that Au@Rh-ICG-CM is able to effectively convert endogenous hydroge

224 Au@Rh-ICG-CM shows good biocompatibility, high tumor accumulat

225 phasic Rh-based core-shell nanosystem (Au@Rh-ICG-CM) is developed to address tumor hypoxia while achi

226 ures (simple disease activity index [SDAI]), ICG-enhanced optical imaging, and DCE MR imaging.

227 Controlled rheological properties of HD/Se/ICG gel may provide easy injectability and slow biodegra

228 HD/Se/ICG gel structure was remained in the mouse for 2 weeks

229 Intratumoral injection of HD/Se/ICG gel with NIR laser irradiation provided the most eff

230 HD/Se/ICG hydrogel structure can be introduced as a promising

231 In the acute stage, ICG-A revealed sharply delineated dense hypofluorescent

232 After SWIFT, ICG imaging indicates that the ILM flap is intact and in

233 ct-LSCI can produce greater information than ICG-VA and that continuous display of data is advantageo

234 Our research confirms that ICG is a voltage-sensitive dye with a dual-component (fa

235 In vivo NIR imaging demonstrated that ICG conjugated micelles prolonged its circulation and in

236 We previously demonstrated that ICG-001, a small molecule specific inhibitor of the beta

237 We report here that ICG-001 (5 mg/kg per day) significantly inhibits beta-ca

238 Results showed that ICG-001 inhibited C666-1 cell growth and reduced express

239 These results suggest that ICG conjugated micelles can be potentially utilized for

240 The ICG fluorescence signal was analyzed with Ad Hoc imaging

241 The ICG is a public-access research facility consisting of a

242 The ICG pHLIP imaging agent marked high-grade urothelial car

243 The ICG-r15 test is an effective tool for assessment of PH i

244 ZWC coating did not significantly affect the ICG distribution in tumors due to the rapid release of t

245 estinal endoscopy, HVPG measurement, and the ICG 15-minute retention (ICG-r15) test.

246 though this would not replace endoscopy, the ICG-r15 appears able to identify patients with advanced

247 Furthermore, the ICG-EPI NPs exhibited inappreciable toxicity.

248 Importantly, the ICG-EPI NPs showed excellent tumor targeting ability wit

249 OCT image and excite the fluorescence in the ICG dye.

250 saline and instilled with a solution of the ICG pHLIP construct, incubated, and rinsed.

251 uated the sensitivity and specificity of the ICG retention test and other noninvasive tools for the d

252 We estimated that the Tth of the ICG-NPs should be controlled at ~38-40 degrees C (slight

253 an AMD scar, a treatable HS was found on the ICG at the border of the disciform scar.

254 hydroxyl or carboxyl function groups on the ICG-NPs for future molecular targeting.

255 A live mixing channel overlaid the ICG sequence on the coronal OCT slices in a fourth panel

256 seen using white light, so imaging with the ICG pHLIP peptide offers improved early diagnosis of bla

257 These ICG conjugated micelles exhibited significant in vitro p

258 that can be readily imaged in deep tissues, ICG may have significant utility for clinical and basic

259 ddressing a current need for alternatives to ICG parenteral administration.

260 radiated ICG conjugated micelles compared to ICG solution and control in a A375 human melanoma tumor

261 erized in vivo by using Pan-ICG(1:5) and Tra-ICG(1:5), respectively.

262 17 of the 25 patients and the hybrid tracer ICG-(99m)Tc-nanocolloid was shown to outperform "free" I

263 17 of the 25 patients, and the hybrid tracer ICG-(99m)Tc-nanocolloid was shown to outperform free ICG

264 150 uL of NETs (20 uM ICG,) was IV injected via tail vein 1-hour prior to phot

265 on and subretinal haemorrhage should undergo ICG imaging to look for HS.

266 hepatocytes, such as LDL storage and uptake, ICG uptake and release, and glycogen storage.

267 Using ICG-001 in a NOD/SCID/IL2Rgamma(-/-) mouse model of engr

268 for intervention in pulmonary fibrosis using ICG-001, a small molecule that specifically inhibits T-c

269 P/beta- and gamma-catenin interactions using ICG-001 leads to differentiation of pre-B ALL cells and

270 CRC can be visualized intraoperatively using ICG-FI.

271 tudy was to explore the possibility of using ICG to monitor cardiac electrical activity.

272 vestigating NIR-guided SLN mapping utilizing ICG in patients with surgically resectable NSCLC.

273 ocyanine green angiography videoangiography (ICG-VA) imaging, also operable via SurgeON, we found tha

274 t agent for use in surgery, pHLIP ICG, where ICG (indocyanine green) is a surgical fluorescent dye us

275 o the presence of both CSPH and SPH, whereas ICG-r15 and INR were related to EV.

276 Ultra-widefield ICG angiography revealed dilated choroidal vessels and c

277 AF and 24 of these eyes with ultra-widefield ICG angiography.

278 Second window ICG reliably accumulates in invasive pancreatic malignan

279 50% clinically: 52.94% with FFA, 82.35% with ICG, and 86.36% with SS-OCT.

280 Fluorescence angiography with ICG allows intraoperative quantitative assessment of mic

281 Fluorescence angiography with ICG can serve as an intraoperative quality control of mi

282 near-infrared fluorescence angiography with ICG; a software was used for quantitative analysis.

283 the interaction between CBP and catenin with ICG-001 results in the differentiation of quiescent drug

284 This information in combination with ICG and fluorescein angiography can help to optimize dir

285 olecular imaging device, in combination with ICG, readily allowed differentiation between normal and

286 re the factors significantly correlated with ICG-PDR (R = 0.87).

287 The liver function correlating with ICG-PDR can be estimated quantitatively from the signal

288 e acetaminophen revealed strong damage, with ICG half-lives significantly higher than in non-treated

289 , even when no change could be detected with ICG angiography.

290 FMT enhanced with ICG provided depth-resolved imaging of synovitis in PIP

291 Dynamic contrast enhancement with ICG was possible.

292 SLN(s) are more reliably identified with ICG dose >=1 mg, albumin dissolvent, post-injection lung

293 ntagonizing the CBP/catenin interaction with ICG-001 can eliminate drug-resistant CML LICs without de

294 of approximately 120-nm capsules loaded with ICG within salt-cross-linked polyallylamine aggregates,

295 the CBP/beta-catenin signaling pathway with ICG-001 can effectively reduce the CSC-like population a

296 ring the second scintigraphic procedure with ICG-(99m)Tc-nanocolloid.

297 ed on Langendorff rabbit hearts stained with ICG and perfused with electromechanical uncouplers.

298 hese two modalities, when used together with ICG, have the potential to help map SLNs in axillary sta

299 egulated in primary ALL after treatment with ICG-001.

300 ng with confocal SLO views, with and without ICG filtration.